Furthermore, any breast-colorectal GWAS signal was less likely to be due to syndromic cases since all cases carrying BRCA1 or BRCA2 or known colorectal cancer susceptibility gene mutations were excluded from the GWAS. This evidence concerns the gene BRCA1 and colorectal cancer.